Auris Health’s Monarch™ Platform integrates the latest advancements in robotics, software, data science, and endoscopy (the use of small cameras and tools to enter the body through its natural openings) to help enable earlier and more accurate diagnosis of small and hard-to-reach nodules in the periphery of the lung.
More than 6,700 new cases of lung cancer are expected to be diagnosed in Georgia in 2021, according to the National Cancer Institute.
“With the increase in lung cancer screening, the number of potential new lung cancers that need diagnosis has grown exponentially,” says Dr. Venkatesh Lakshminarayanan, pulmonologist and medical director of Northside Hospital’s Interventional Pulmonology Program. “Smaller, more peripheral nodules have also arisen.”
“This technology allows for minimally invasive biopsies while being able to maintain direct visualization and control even to the smallest potential cancers,” said Dr. Lakshminarayanan.
“Robotic bronchoscopy is the next stage in being able to biopsy and stage lung cancers in a safe and timely way,” Dr. Lakshminarayanan adds. “It is an evolving field that provides new opportunities for rapid diagnostic and potential therapeutic options in lung cancer.”
Monarch utilizes a familiar controller-like interface that physicians use to navigate the flexible robotic endoscope to the periphery of the lung with improved reach, vision, and control. Combining traditional endoscopic views into the lung with computer-assisted navigation based on 3D models of the patient’s own lung anatomy, the platform provides physicians with continuous bronchoscope vision throughout the entire procedure.